Why the study?
Patients in sub-Saharan Africa generally have poor anticoagulation control, with increasing numbers of patients expected to require anticoagulation due to the growing burden of noncommunicable disease.
Locally developed 'warfarin care bundles' are proposed as a comprehensive solution to address the multiple challenges of poor anticoagulation control in sub-Saharan Africa.
Answers are grounded in this paper and cite their sources.
Should not yet change anticoagulation practice in sub-Saharan Africa; leaves open the value of warfarin care bundles pending prospective trials.
Patients in sub-Saharan Africa generally have poor anticoagulation control. We review the potential reasons for this poor control, as well as the potential solutions. Challenges include the affordability and centralisation of anticoagulation care, problems with access to medicines and international normalised ratio monitoring, the lack of locally validated standardized dosing protocols, and low levels of anticoagulation knowledge among healthcare workers and patients. Increasing numbers of patients will need anticoagulation in the future because of the increasing burden of noncommunicable disease in the region. We propose that locally developed "warfarin care bundles" which address multiple anticoagulation challenges in combination may be the most appropriate solution in this setting currently.
No takes yet. Share an insight, caveat, or question.
Mouton et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: